OptiBiotix Health (LON:OPTI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported GBX (1.52) earnings per share (EPS) for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative return on equity of 77.85% and a negative net margin of 332.69%.
OptiBiotix Health Stock Performance
Shares of LON OPTI remained flat at GBX 5.95 during midday trading on Friday. 580,627 shares of the company were exchanged, compared to its average volume of 359,691. The firm has a market capitalization of £6.15 million, a P/E ratio of -1.55 and a beta of 1.82. The stock’s 50 day moving average is GBX 5.78 and its 200-day moving average is GBX 5.74. OptiBiotix Health has a fifty-two week low of GBX 4.50 and a fifty-two week high of GBX 12.25.
About OptiBiotix Health
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Featured Articles
- Five stocks we like better than OptiBiotix Health
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
